| 1 |
Misbranded ASU Drugs (33E) |
Definition of misbranded ASU drugs. |
ACTIVE |
2025-03-19 06:10:28 |
1 |
2025-03-19 06:10:28 |
1 |
| 2 |
Adulterated ASU Drugs (33EE) |
Definition of adulterated ASU drugs. |
ACTIVE |
2025-03-19 06:10:28 |
1 |
2025-03-19 06:10:28 |
1 |
| 3 |
Spurious ASU Drugs (33EEA) |
Definition of spurious ASU drugs. |
ACTIVE |
2025-03-19 06:10:28 |
1 |
2025-03-19 06:10:28 |
1 |
| 4 |
Standards of ASU Drugs (33EEB) |
Standards of identity, purity, and strength for AS... |
ACTIVE |
2025-03-19 06:10:28 |
1 |
2025-03-19 06:10:28 |
1 |
| 5 |
Prohibition by State Government (33EEC) |
Prohibition on manufacturing and sale of ASU drugs... |
ACTIVE |
2025-03-19 06:10:28 |
1 |
2025-03-19 06:10:28 |
1 |
| 6 |
Prohibition by Central Government (33EED) |
Prohibition on manufacturing, sale, etc. of ASU dr... |
ACTIVE |
2025-03-19 06:10:28 |
1 |
2025-03-19 06:10:28 |
1 |
| 7 |
Penalties (33-I, 33-J) |
Penalties for contraventions related to ASU drugs. |
ACTIVE |
2025-03-19 06:10:28 |
1 |
2025-03-19 06:10:28 |
1 |
| 8 |
Confiscation of Stock (33K) |
Confiscation of the stock of ASU drugs found in vi... |
ACTIVE |
2025-03-19 06:10:28 |
1 |
2025-03-19 06:10:28 |
1 |
| 9 |
Disclosure of Information to Inspector (33KA) |
Disclosure of ASU drug information to the inspecto... |
ACTIVE |
2025-03-19 06:10:28 |
1 |
2025-03-19 06:10:28 |
1 |
| 10 |
Maintenance of Records (33KB) |
Maintenance of records and furnishing information ... |
ACTIVE |
2025-03-19 06:10:28 |
1 |
2025-03-19 06:10:28 |
1 |
| 11 |
Cognizance of Offences (33M) |
Legal cognizance of offences related to ASU drugs. |
ACTIVE |
2025-03-19 06:10:28 |
1 |
2025-03-19 06:10:28 |
1 |
| 12 |
First Schedule |
List of Authoritative texts for ASU medicines. |
ACTIVE |
2025-03-19 06:14:56 |
1 |
2025-03-19 06:14:56 |
1 |
| 13 |
Rule 2(dd) |
Definition of Homeopathic drugs. |
ACTIVE |
2025-03-19 06:14:56 |
1 |
2025-03-19 06:14:56 |
1 |
| 14 |
Schedule E(1) |
List of poisonous substances under the ASU system ... |
ACTIVE |
2025-03-19 06:14:56 |
1 |
2025-03-19 06:14:56 |
1 |
| 15 |
Schedule T |
Good Manufacturing Practices (GMP) for ASU medicin... |
ACTIVE |
2025-03-19 06:14:56 |
1 |
2025-03-19 06:14:56 |
1 |
| 16 |
Schedule TA |
Form for recording the utilization of raw material... |
ACTIVE |
2025-03-19 06:14:56 |
1 |
2025-03-19 06:14:56 |
1 |
| 17 |
Schedule M1 |
GMP for Homeopathic drugs. |
ACTIVE |
2025-03-19 06:14:56 |
1 |
2025-03-19 06:14:56 |
1 |
| 18 |
Schedule B1 |
Fee for analysis of ASU&H drugs at PCIM&H. |
ACTIVE |
2025-03-19 06:14:56 |
1 |
2025-03-19 06:14:56 |
1 |
| 19 |
Schedule Y |
Guidelines for clinical studies. |
ACTIVE |
2025-03-19 06:14:56 |
1 |
2025-03-19 06:14:56 |
1 |
| 20 |
Rules 151-169 |
Provisions under the Drugs Rules, 1945 for ASU dru... |
ACTIVE |
2025-03-19 06:19:28 |
1 |
2025-03-19 06:19:28 |
1 |
| 21 |
Rule 153 |
Application for a license to manufacture ASU drugs... |
ACTIVE |
2025-03-19 06:19:28 |
1 |
2025-03-19 06:19:28 |
1 |
| 22 |
Rule 153B |
Application for Certificate of GMP for ASU drugs m... |
ACTIVE |
2025-03-19 06:19:28 |
1 |
2025-03-19 06:19:28 |
1 |
| 23 |
Rule 155B |
Award of GMP certification for ASU drugs in Form 2... |
ACTIVE |
2025-03-19 06:19:28 |
1 |
2025-03-19 06:19:28 |
1 |
| 24 |
Rule 156B |
Duration of Certificate of GMP for ASU drugs manuf... |
ACTIVE |
2025-03-19 06:19:28 |
1 |
2025-03-19 06:19:28 |
1 |
| 25 |
Rule 157 |
Guidelines for GMP certification issuance as per S... |
ACTIVE |
2025-03-19 06:19:28 |
1 |
2025-03-19 06:19:28 |
1 |